- The 8 States Most Likely to Legalize Marijuana Next
- Dow 18,000: Why This Market Rally May Never Happen Again
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
- BlackBerry Classic Review: A Bold Update for CrackBerry Fans
It's a good example of the wrong way to shop your company.
Leveraged buyouts show no signs of slowing down.
A private-equity firm is buying some of Ritchie Capital's assets.
Emanuel Friedman is punished for his role in a PIPE trading scheme.
Regulators sue Morgan Stanley for using 9/11 as a litigation excuse.
It demands a strategic review, but the retailer says it just did one.
The investment firm tried to get a lot more than its $40 million deal fee from the big buyout.
The firms link up in a mutual fund trade-execution deal.
Earnings at the firms can't compare to Goldman Sachs' performance.